Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance

International Journal of Pharmaceutics

Volumn 489, Issue 1-2, 2015, Pages 318-330

  Jia, Lejiao ^a   Li, Zhenyu ^b   Shen, Jingyi ^b   Zheng, Dandan ^b   Tian, Xiaona ^b   Guo, Hejian ^b   Chang, Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Co delivery; Mesoporous silica nanoparticles; Multidrug resistance; Paclitaxel; Tetrandrine

Indexed keywords

CETRIMIDE; PACLITAXEL; SILICA NANOPARTICLE; TETRANDRINE; ANTINEOPLASTIC AGENT; BENZYLISOQUINOLINE DERIVATIVE; DRUG CARRIER; MICELLE; NANOPARTICLE; SILICON DIOXIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; MICELLE; MULTIDRUG RESISTANCE; PARTICLE SIZE; PH; PRIORITY JOURNAL; X RAY DIFFRACTION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; POROSITY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZYLISOQUINOLINES; CELL SURVIVAL; CETRIMONIUM COMPOUNDS; DRUG CARRIERS; DRUG LIBERATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MCF-7 CELLS; MICELLES; NANOPARTICLES; PACLITAXEL; POROSITY; SILICON DIOXIDE;

EID: 84929340171     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.05.010     Document Type: Article

References (51)

1. C.E. Ashley, E.C. Carnes, K.E. Epler, D.P. Padilla, G.K. Phillips, R.E. Castillo, D.C. Wilkinson, B.S. Wilkinson, C.A. Burgard, R.M. Kalinich, J.L. Townson, B. Chackerian, C.L. Willman, D.S. Peabody, W. Wharton, and C.J. Brinker Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers ACS Nano 6 2012 2174 2188
2. D. Belotti, V. Vergani, T. Drudis, P. Borsotti, M.R. Pitelli, G. Viale, R. Giavazzi, and G. Taraboletti The microtubule-affecting drug paclitaxel has antiangiogenic activity Clin. Cancer Res. 2 1996 1843 1849
3. R. Bleday, M.J. Weiss, R.R. Salem, R.E. Wilson, L.B. Chen, and G. Steele Jr. Inhibition of rat colon tumor isograft growth with dequalinium chloride Arch. Surg. 121 1986 1272 1275
4. Y. Chen, Q. Yin, X. Ji, S. Zhang, H. Chen, Y. Zheng, Y. Sun, H. Qu, Z. Wang, Y. Li, X. Wang, K. Zhang, L. Zhang, and J. Shi Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells Biomaterials 33 2012 7126 7137
5. Y. Chen, H. Chen, and J. Shi In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles Adv. Mater. 25 2013 3144 3176
6. Y. Chen, H. Chen, and J. Shi Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells Mol. Pharm. 11 2014 2495 2510
7. Y. Chen, Q. Meng, M. Wu, S. Wang, P. Xu, H. Chen, Y. Li, L. Zhang, L. Wang, and J. Shi Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine J. Am. Chem. Soc. 136 2014 16326 16334
8. Y.J. Chen Potential role of tetrandrine in cancer therapy Acta Pharmacol. Sin. 23 2002 1102 1106
9. J. Choi, T. Konno, M. Takai, and K. Ishihara Regulation of cell proliferation by multi-layered phospholipid polymer hydrogel coatings through controlled release of paclitaxel Biomaterials 33 2011 954 961
10. S.D. Conner, and S.L. Schmid Regulated portals of entry into the cell Nature 422 2003 37 44
11. S.S. D'Souza, and P.P. DeLuca Methods to assess in vitro drug release from injectable polymeric particulate systems Pharm. Res. 23 2006 460 474
12. C.L. Dai, H.Y. Xiong, L.F. Tang, X. Zhang, Y.J. Liang, M.S. Zeng, L.M. Chen, X.H. Wang, and L.W. Fu Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice Cancer Chemother. Pharmacol. 60 2007 741 750
13. P.D. Eckford, and F.J. Sharom ABC efflux pump-based resistance to chemotherapy drugs Chem. Rev. 109 2009 2989 3011
14. G.D. Eytan Mechanism of multidrug resistance in relation to passive membrane permeation Biomed. Pharmacother. 59 2005 90 97
15. L. Fan, F. Li, H. Zhang, Y. Wang, C. Cheng, X. Li, C.H. Gu, Q. Yang, H. Wu, and S. Zhang Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance Biomaterials 31 2010 5634 5642
16. G.A. Fisher, B.L. Lum, J. Hausdorff, and B.I. Sikic Pharmacological considerations in the modulation of multidrug resistance Eur. J. Cancer 32A 1996 1082 1088
17. P.M. Fracasso, M.F. Brady, D.H. Moore, J.L. Walker, P.G. Rose, L. Letvak, T.M. Grogan, and W.P. McGuire Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study J. Clin. Oncol. 19 2001 2975 2982
18. L. Fu, Y. Liang, L. Deng, Y. Ding, L. Chen, Y. Ye, X. Yang, and Q. Pan Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance Cancer Chemother. Pharmacol. 53 2004 349 356
19. E. Georges, F.J. Sharom, and V. Ling Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy Adv. Pharmacol. 21 1990 185 220
20. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2 2002 48 58
21. Q. He, J. Shi, F. Chen, M. Zhu, and L. Zhang An anticancer drug delivery system based on surfactantlated mesoporous silica nanoparticles Biomaterials 31 2010 3335 3346
22. Q. He, Y. Gao, L. Zhang, Z. Zhang, F. Gao, X. Ji, Y. Li, and J. Shi A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance Biomaterials 32 2011 7711 7720
23. Q. Huo, D.I. Margolese, P. Feng, T. Gier, and P. Sieger Generalized syntheses of periodic surfactant/inorganic composite materials DTIC Doc. 368 1994 317 321
24. P.L. Kuo, and C.C. Lin Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells Life Sci. 73 2003 243 252
25. A.K. Larsen, A.E. Escargueil, and A. Skladanowski Resistance mechanisms associated with altered intracellular distribution of anticancer agents Pharmacol. Ther. 85 2000 217 229
26. J.H. Lee, G.H. Kang, K.C. Kim, K.M. Kim, D.I. Park, B.T. Choi, H.S. Kang, Y.T. Lee, and Y.H. Choi Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells Int. J. Oncol. 21 2002 1239
27. X. Li, P. Li, Y. Zhang, Y. Zhou, X. Chen, Y. Huang, and Y. Liu Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously Pharm. Res. 27 2010 1498 1511
28. W.B. Liechty, and N.A. Peppas Expert opinion: responsive polymer nanoparticles in cancer therapy Eur. J. Pharm. Biopharm. 80 2012 241 246
29. M. Liu, L. Gan, L. Chen, D. Zhu, Z. Xu, and Z. Hao A novel liposome-encapsulated hemoglobin/silica nanoparticle as an oxygen carrier Int. J. Pharm. 427 2012 354 357
30. T.W. Loo, and D.M. Clarke Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux J. Membr. Biol. 206 2005 173 185
31. S. Mayor, and R.E. Pagano Pathways of clathrin-independent endocytosis Nat. Rev. Mol. Cell Biol. 8 2007 603 612
32. S. Mornet, O. Lambert, E. Duguet, and A. Brisson The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy Nano Lett. 5 2005 281 285
33. S. Mukherjee, R.N. Ghosh, and F.R. Maxfield Endocytosis Physiol. Rev. 77 1997 759 803
34. G.D. Pennock, W.S. Dalton, W.R. Roeske, C.P. Appleton, K. Mosley, P. Plezia, T.P. Miller, and S.E. Salmon Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration J. Natl. Cancer Inst. 83 1991 105 110
35. A. Prokop, and J.M. Davidson Nanovehicular intracellular delivery systems J. Pharm. Sci. 97 2008 3518 3590
36. J.Q. Qian Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives Acta Pharmacol. Sin. 23 2002 1086 1092
37. F. Tang, L. Li, and D. Chen Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery Adv. Mater. 24 2012 1504 1534
38. M.J. Thomas, I. Slipper, A. Walunj, A. Jain, M.E. Favretto, P. Kallinteri, and D. Douroumis Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles Int. J. Pharm. 387 2010 272 277
39. B.G. Trewyn, S. Giri, I.I. Slowing, and V.S. Lin Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems Chem. Commun. (Camb.) 31 2007 3236 3245
40. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res. 49 1989 6449 6465
41. Y. Wang, L. Yu, L. Han, X. Sha, and X. Fang Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines Int. J. Pharm. 337 2007 63 73
42. M.J. Weiss, J.R. Wong, C.S. Ha, R. Bleday, R.R. Salem, G.D. Steele Jr., and L.B. Chen Dequalinium a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation Proc. Natl. Acad. Sci. U. S. A. 84 1987 5444 5448
43. Q.M. Xie, H.F. Tang, J.Q. Chen, and R.L. Bian Pharmacological actions of tetrandrine in inflammatory pulmonary diseases Acta Pharmacol. Sin. 23 2002 1107 1113
44. X. Xing, X. He, J. Peng, K. Wang, and W. Tan Uptake of silica-coated nanoparticles by HeLa cells J. Nanosci. Nanotechnol. 5 2005 1688 1693
45. K.W. Yip, X. Mao, P.Y. Au, D.W. Hedley, S. Chow, S. Dalili, J.D. Mocanu, C. Bastianutto, A. Schimmer, and F.F. Liu Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen Clin. Cancer Res. 12 2006 5557 5569
46. Y.H. Yu, E. Kim, D.E. Park, G. Shim, S. Lee, Y.B. Kim, C.W. Kim, and Y.K. Oh Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA Eur. J. Pharm. Biopharm. 80 2012 268 273
47. X.G. Zhang, J. Miao, Y.Q. Dai, Y.Z. Du, H. Yuan, and F.Q. Hu Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells Int. J. Pharm. 361 2008 239 244
48. Y. Zhang, J. Wang, X. Bai, T. Jiang, Q. Zhang, and S. Wang Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs Mol. Pharm. 9 2012 505 513
49. B.X. Zhao, Y. Zhao, Y. Huang, L.M. Luo, P. Song, X. Wang, S. Chen, K.F. Yu, X. Zhang, and Q. Zhang The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel Biomaterials 33 2012 2508 2520
50. X. Zhu, M. Sui, and W. Fan In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel Anticancer Res. 25 2005 1953 1962
51. C. Zhu, S. Jung, S. Luo, F. Meng, X. Zhu, T.G. Park, and Z. Zhong Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers Biomaterials 31 2010 2408 2416